About Senseonics
Senseonics is a company based in Germantown (United States) founded in 1996. Senseonics has raised $175.46 million across 17 funding rounds from investors including Oxford Finance, Greenspring Associates and Roche. The company has 117 employees as of December 31, 2024. Senseonics offers products and services including Eversense CGM and Eversense System. Senseonics operates in a competitive market with competitors including Dexcom, Livongo, Bigfoot Biomedical, One Drop and mySugr, among others.
- Headquarter Germantown, United States
- Employees 117 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Senseonics Holdings, Inc.
-
Annual Revenue
$22.47 M (USD)0.37as on Dec 31, 2024
-
Net Profit
-$78.62 M (USD)-30.18as on Dec 31, 2024
-
EBITDA
-$73.37 M (USD)1.29as on Dec 31, 2024
-
Total Equity Funding
$175.46 M (USD)
in 17 rounds
-
Latest Funding Round
$20.27 M (USD), Post-IPO
May 20, 2025
-
Investors
Oxford Finance
& 6 more
-
Employee Count
117
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Senseonics
Senseonics is a publicly listed company on the AMEX with ticker symbol SENS in USA, operating in the Electronic technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Senseonics
Senseonics offers a comprehensive portfolio of products and services, including Eversense CGM and Eversense System.
Implantable system for accurate long-term glucose tracking in diabetes patients.
Next-generation implantable sensor for up to 180-day continuous monitoring.
People of Senseonics
Unlock access to complete
Software Development Team
20 people
Leadership Team
15 people
Operations Team
5 people
Senior Team
5 people
Clinical Team
3 people
Data Analysis and Operations Team
3 people
Finance and Accounting
3 people
Product Management Team
3 people
Unlock access to complete
Funding Insights of Senseonics
Senseonics has successfully raised a total of $175.46M across 17 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20.27 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Senseonics
Senseonics has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Oxford Finance, Greenspring Associates and Roche.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital firm focused on the healthcare sector
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked |
Investor details for Senseonics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Senseonics
Investment portfolio details for Senseonics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Senseonics
Detailed financials for Senseonics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Senseonics Comparisons
Peer comparison for Senseonics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Senseonics
Senseonics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, Bigfoot Biomedical, One Drop and mySugr, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| Locked | Locked | Locked |
Provider of smart devices for diabetes management for patients and doctors
|
|
| Locked | Locked | Locked |
Developer of a closed-loop automated insulin delivery system
|
|
| Locked | Locked | Locked |
Provider of workforce healthcare solutions
|
|
| Locked | Locked | Locked |
Gamified apps for diabetes management and therapy are provided.
|
Detailed competitors of Senseonics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Senseonics
Complete news archive for Senseonics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Senseonics
Senseonics was founded in 1996 and raised its 1st funding round 6 years after it was founded.
Senseonics is headquartered in Germantown, United States.
Tim Goodnow is the current CEO of Senseonics.
Senseonics is a funded company, having raised a total of $175.46M across 17 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Senseonics is 117.
Annual revenue of Senseonics is $22.47M as on Dec 31, 2024.
Senseonics was founded in 1996 and is headquartered in Germantown, United States. Continuous glucose monitoring systems for diabetes patients are designed, developed, and commercialized by the company. An implantable sensor, paired with a transmitter and mobile application, is utilized to track glucose levels for up to 90 days. The sensor is inserted into the upper arms subcutaneous tissue and transmits data wirelessly without batteries or wires.
Senseonics's top competitors include Dexcom, Bigfoot Biomedical and One Drop.
Senseonics offers Eversense CGM and Eversense System.
Yes, Senseonics is publicly traded on AMEX under the ticker symbol SENS.
Senseonics has 7 investors. Key investors include Oxford Finance, Greenspring Associates, Roche, NEA, and Anthem Capital.
The ticker symbol of Senseonics is SENS on AMEX.